Kaplan Meir analysis of survival from the date of diagnosis was calculated for both groups. 5 year-survival for the transplanted group (n=25) was compared to the non-transplanted group (n=20) was 80.2% vs. 65.7%, respectively (Log-rank, p=0.11).

Figure 2: Comparison of survival analysis for MM and Lymphoma patients who underwent auto-transplantation and those referred to the transplant center but not transplanted.